Loading...
Glioblastoma Resistance to Anti-VEGF Therapy: Has the Challenge Been MET?
In glioblastoma cells the receptor tyrosine kinase c-Met is upregulated in response to Bevacizumab and plays an important role in promoting invasion and tumor recurrence. These data support novel links between VEGF-A and HGF and suggest that c-Met and its signaling effectors may be effective targets...
Na minha lista:
| Hovedforfatter: | |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3618531/ https://ncbi.nlm.nih.gov/pubmed/23403631 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-13-0051 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|